
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.1M | $4.1M | $4.2M | $6.8M | $4M | |
Revenue Growth (YoY) | -- | 1.49% | 0.84% | 63.69% | -42.11% | |
Cost of Revenues | $3.3M | $3.3M | $3.4M | $4.4M | $3.5M | |
Gross Profit | $735.2K | $859.8K | $785.7K | $2.4M | $412.2K | |
Gross Profit Margin | 18.04% | 20.79% | 18.84% | 35.76% | 10.43% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $592.5K | $1.2M | $1.4M | $3.2M | $3M | |
Other Inc / (Exp) | $190.2K | $19.4K | $80K | $183.8K | $134.7K | |
Operating Expenses | $592.5K | $1.2M | $1.4M | $3.2M | $3M | |
Operating Income | $142.6K | -$360.9K | -$641.5K | -$771.1K | -$2.5M | |
Net Interest Expenses | $49.2K | $13.3K | $35.4K | $61.6K | $129.8K | |
EBT. Incl. Unusual Items | $283.6K | -$354.7K | -$596.9K | -$648.9K | -$2.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5.5K | -- | -- | -- | -- | |
Net Income to Company | $278K | -$354.7K | -$596.9K | -$648.9K | -$2.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $278K | -$354.7K | -$596.9K | -$648.9K | -$2.5M | |
Basic EPS (Cont. Ops) | $0.02 | -$0.02 | -$0.04 | -$0.04 | -$0.17 | |
Diluted EPS (Cont. Ops) | $0.02 | -$0.02 | -$0.04 | -$0.04 | -$0.17 | |
Weighted Average Basic Share | $15M | $15M | $15M | $14.3M | $15.2M | |
Weighted Average Diluted Share | $15M | $15M | $15M | $14.3M | $15.2M | |
EBITDA | $339K | -$337.8K | -$558.9K | -$578.9K | -$2.4M | |
EBIT | $332.8K | -$341.4K | -$561.5K | -$587.3K | -$2.4M | |
Revenue (Reported) | $4.1M | $4.1M | $4.2M | $6.8M | $4M | |
Operating Income (Reported) | $142.6K | -$360.9K | -$641.5K | -$771.1K | -$2.5M | |
Operating Income (Adjusted) | $332.8K | -$341.4K | -$561.5K | -$587.3K | -$2.4M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $4.1M | $4.2M | $6.8M | $4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $3.3M | $3.4M | $4.4M | $3.5M | |
Gross Profit | -- | $859.8K | $785.7K | $2.4M | $412.2K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $1.2M | $1.4M | $3.2M | $3M | |
Other Inc / (Exp) | -- | $19.4K | $79.9K | $183.8K | $134.7K | |
Operating Expenses | -- | $1.2M | $1.4M | $3.2M | $3M | |
Operating Income | -- | -$360.9K | -$641.5K | -$771.1K | -$2.5M | |
Net Interest Expenses | -- | $13.3K | $35.4K | $61.6K | $129.8K | |
EBT. Incl. Unusual Items | -- | -$354.7K | -$596.9K | -$648.9K | -$2.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$354.7K | -$596.9K | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$354.7K | -$596.9K | -$648.9K | -$2.5M | |
Basic EPS (Cont. Ops) | -- | -$0.02 | -$0.04 | -$0.04 | -$0.17 | |
Diluted EPS (Cont. Ops) | -- | -$0.02 | -$0.04 | -$0.04 | -$0.17 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$337.8K | -$558.9K | -$587.3K | -$2.4M | |
EBIT | -- | -$341.4K | -$561.5K | -$587.3K | -$2.4M | |
Revenue (Reported) | -- | $4.1M | $4.2M | $6.8M | $4M | |
Operating Income (Reported) | -- | -$360.9K | -$641.5K | -$771.1K | -$2.5M | |
Operating Income (Adjusted) | -- | -$341.4K | -$561.5K | -$587.3K | -$2.4M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $8.2K | $537.7K | $609.6K | $5.2M | $4.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.2M | $749K | $1.1M | $4.1M | $2.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $16.1K | $16.6K | $159.7K | $188.8K | $170.7K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2M | $2.3M | $2.9M | $11.3M | $6.8M | |
Property Plant And Equipment | $8.1K | $4.4K | $1.8K | $272.4K | $142.8K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.1M | $2.4M | $3.1M | $11.8M | $8.7M | |
Accounts Payable | $739.4K | $694.6K | $937K | $1.2M | $558.2K | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $61.1K | $258.5K | $455.1K | $1.1M | $1.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $123.5K | $100.9K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $2.9M | $2.8M | $4.2M | $5.1M | $4.8M | |
Long-Term Debt | -- | $752.9K | $653.2K | $552.5K | $447.1K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.9M | $3.5M | $4.8M | $5.8M | $5.2M | |
Common Stock | -- | -- | -- | $8.4M | $8.4M | |
Other Common Equity Adj | -- | $5.3K | $5.2K | $26.4K | $56.4K | |
Common Equity | -$765.7K | -$1.1M | -$1.7M | $6M | $3.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$765.7K | -$1.1M | -$1.7M | $6M | $3.5M | |
Total Liabilities and Equity | $2.1M | $2.4M | $3.1M | $11.8M | $8.7M | |
Cash and Short Terms | $8.2K | $537.7K | $609.6K | $5.2M | $4.3M | |
Total Debt | $358.2K | $1M | $1.1M | $1.7M | $2.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $537.7K | $609.6K | $5.2M | $4.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $749K | $1.1M | $4.1M | $2.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | $16.6K | $159.7K | $188.8K | $170.7K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $2.3M | $2.9M | $11.3M | $6.8M | |
Property Plant And Equipment | -- | $4.4K | $1.8K | $272.4K | $142.8K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $2.4M | $3.1M | $11.8M | $8.7M | |
Accounts Payable | -- | $694.6K | $937K | $1.2M | $558.2K | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | $258.5K | $455.1K | $1.1M | $1.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $123.5K | $100.9K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $2.8M | $4.2M | $5.1M | $4.8M | |
Long-Term Debt | -- | $752.9K | $653.2K | $552.5K | $447.1K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $3.5M | $4.8M | $5.8M | $5.2M | |
Common Stock | -- | -- | -- | $8.4M | $8.4M | |
Other Common Equity Adj | -- | $5.3K | $5.2K | $26.4K | $56.4K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -$1.1M | -$1.7M | $6M | $3.5M | |
Total Liabilities and Equity | -- | $2.4M | $3.1M | $11.8M | $8.7M | |
Cash and Short Terms | -- | $537.7K | $609.6K | $5.2M | $4.3M | |
Total Debt | -- | $1M | $1.1M | $1.7M | $2.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $278K | -$354.7K | -$596.9K | -$648.9K | -$2.5M | |
Depreciation & Amoritzation | $6.2K | $3.6K | $2.6K | $8.4K | $15K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$251.6K | $112.3K | -$635.5K | -$4M | $1.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$74.4K | -$482.8K | -$352.8K | -$3.8M | -$1.6M | |
Capital Expenditures | $2.9K | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.9K | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $998.3K | $2.1M | $537.4K | $2M | $5.3M | |
Long-Term Debt Repaid | -$1.9M | -$1.4M | -$440.6K | -$1.4M | -$4.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $939.6K | $360.9K | $325.8K | -$524.8K | $11.8K | |
Cash From Financing | $83.9K | $1M | $422.5K | $8.4M | $634.7K | |
Beginning Cash (CF) | $7.4K | $8.2K | $537.7K | $609.6K | $5.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.6K | $535.4K | $69.8K | $4.6M | -$935.3K | |
Ending Cash (CF) | $8.2K | $537.7K | $609.6K | $5.2M | $4.3M | |
Levered Free Cash Flow | -$77.3K | -$482.8K | -$352.8K | -$3.8M | -$1.6M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$354.7K | -$596.9K | |
Depreciation & Amoritzation | -- | -- | -- | $3.6K | $2.6K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | $112.3K | -$635.5K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$482.8K | -$352.8K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $2.1M | $537.4K | |
Long-Term Debt Repaid | -- | -- | -- | -$1.4M | -$440.6K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $360.9K | $325.8K | |
Cash From Financing | -- | -- | -- | $1M | $422.5K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $541.1K | $77.7K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$482.8K | -$352.8K |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.